1. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma
    Wei Liu et al, 2017, J Int Med Res CrossRef
  2. miR-191/DAB2 Axis Regulates the Tumorigenicity of Estrogen Receptor-Positive Breast Cancer
    Xinxin Tian et al, 2017, IUBMB Life CrossRef
  3. MicroRNA regulatory networks reflective of polyhexamethylene guanidine phosphate-induced fibrosis in A549 human alveolar adenocarcinoma cells
    Da Young Shin et al, 2018, Toxicology Letters CrossRef
  4. A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia
    Laixi Bi et al, 2018, BMC Cancer CrossRef
  5. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
    Ramesh Butti et al, 2018, Mol Cancer CrossRef
  6. Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
    Yinghua Zhu et al, 2018, Nat Commun CrossRef
  7. Role of HOX Genes in Stem Cell Differentiation and Cancer
    Seema Bhatlekar et al, 2018, Stem Cells International CrossRef
  8. Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer
    Michela Coan et al, 2018, IJMS CrossRef
  9. The Network of Non-coding RNAs in Cancer Drug Resistance
    Fabio Corrà et al, 2018, Front. Oncol. CrossRef
  10. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression
    Huijuan Feng et al, 2019, J Cell Physiol CrossRef
  11. Prevention of breast cancer by dietary polyphenols—role of cancer stem cells
    Hao-Feng Gu et al, 2019, Critical Reviews in Food Science and Nutrition CrossRef
  12. miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer.
    Xu-chen Cao, 0 CrossRef
  13. A Case of Identity: HOX Genes in Normal and Cancer Stem Cells
    null Smith et al, 2019, Cancers CrossRef
  14. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies
    null Khan et al, 2019, Cells CrossRef
  15. null
    Mohd Farhan et al, 2019 CrossRef
  16. The role of upregulated miR-375 expression in breast cancer: an in vitro and in silico study
    Wei Tang et al, 2019, Pathology - Research and Practice CrossRef
  17. Chemotherapeutic Stress Influences Epithelial-Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer.
    Xiao Li et al, 2020, Int J Mol Sci CrossRef
  18. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction
    Dharambir Kashyap et al, 2020, Life Sciences CrossRef
  19. HOX genes function in Breast Cancer development
    Simone Aparecida de Bessa Garcia et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  20. Contributions of HOX genes to cancer hallmarks: Enrichment pathway analysis and review
    Danielle Barbosa Brotto et al, 2020, Tumour Biol. CrossRef
  21. Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade
    Xiaorong Lin et al, 2020, Cell Reports CrossRef
  22. Circ-PRKDC Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells by Regulating miR-375/FOXM1 Axis and Wnt/β-Catenin Pathway.
    Hao Chen et al, 2020, Onco Targets Ther CrossRef
  23. Plasma extracellular vesicle‑packaged microRNAs as candidate diagnostic biomarkers for early‑stage breast cancer
    Chen Yan et al, 2019, Mol Med Report CrossRef
  24. MicroRNA-10b-5p downregulation inhibits the invasion of glioma cells via modulating homeobox B3 expression.
    Weiling Li et al, 2019, Exp Ther Med CrossRef
  25. MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling
    Qiong Zhao et al, 2020, European Journal of Pharmacology CrossRef
  26. miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers
    Yulei Wei et al, 2020, Breast Cancer CrossRef
  27. Loss of HOXB3 correlates with the development of hormone receptor negative breast cancer.
    Lizhe Zhu et al, 2020, PeerJ CrossRef
  28. Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells
    Amelia Weber Hall et al, 2018, Cancer Res CrossRef
  29. MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer.
    Tong Niu et al, 2021, Cancer Cell Int CrossRef
  30. Signaling pathways governing breast cancer stem cells behavior.
    Kai Song et al, 2021, Stem Cell Res Ther CrossRef
  31. The Impact of lncRNAs and miRNAs in Regulation of Function of Cancer Stem Cells and Progression of Cancer.
    Soudeh Ghafouri-Fard et al, 2021, Front Cell Dev Biol CrossRef
  32. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer
    Jingjing Wu et al, 2021, Aging CrossRef
  33. MicroRNAs as a clue to overcome breast cancer treatment resistance
    Iris Garrido-Cano et al, 2021, Cancer Metastasis Rev CrossRef
  34. Downregulation of RPS14 inhibits the proliferation and metastasis of estrogen receptor-positive breast cancer cells
    Xiu Wang et al, 2021 CrossRef
  35. Contribution of miRNAs in the Pathogenesis of Breast Cancer
    Soudeh Ghafouri-Fard et al, 2021, Front. Oncol. CrossRef
  36. MicroRNA-375: potential cancer suppressor and therapeutic drug.
    Jiahui Wei et al, 2021, Biosci Rep CrossRef
  37. Extracellular Vesicle-Encapsulated MicroRNA-375 from Bone Marrow-Derived Mesenchymal Stem Cells Inhibits Hepatocellular Carcinoma Progression through Regulating HOXB3-Mediated Wnt/β-Catenin Pathway
    Zhaoxia Yu et al, 2022, Analytical Cellular Pathology CrossRef
  38. Overview of MicroRNA Expression in Predicting Response to Neoadjuvant Therapies in Human Epidermal Growth Receptor-2 Enriched Breast Cancer – A Systematic Review
    Matthew G Davey et al, 2022, Breast Cancer�(Auckl) CrossRef
  39. Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
    Mehrdokht Sadrkhanloo et al, 2022, European Journal of Pharmacology CrossRef
  40. Prognostic value of micro-RNA 375, 133, 143, 145 in esophageal carcinoma: A systematic review and meta-analysis
    Pinhao Fang et al, 2022, Front. Oncol. CrossRef
  41. CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR ‐375/ SLC7A11 axis
    Jiayun Liu et al, 2022, Environmental Toxicology CrossRef
  42. EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
    Mehrdad Hashemi et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  43. The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy
    Lorena Alexandra Lisencu et al, 2022, Medicina CrossRef
  44. Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
    Nina Petrović et al, 2021, J Mammary Gland Biol Neoplasia CrossRef
  45. RNA interference: Promising approach for breast cancer diagnosis and treatment
    Elham Allahyari et al, 2022, Cell Biology International CrossRef
  46. The Regulation Role of Ferroptosis Mechanism of Anti-Cancer Drugs and Noncoding RNAs
    Mine Ensoy et al, 2023, CMC CrossRef
  47. Extracellular Vesicles Act as Carriers for Cargo Delivery and Regulate Wnt Signaling in the Hepatocellular Carcinoma Tumor Microenvironment
    Risheng He et al, 2023, Cancers CrossRef